GlassScriptPhysician profile
Melanie Lynn Mcnally
NPI 1427072776
$5,098.70
in general payments reported to CMS, 2019-2025
36 companies · $36.77 in 2025
The $36.77 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,710 · 2021: $1,092 · 2022: $877 · 2023: $1,287 · 2024: $95.90 · 2025: $36.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,419.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,415.80 | 2019 | |
| Astellas Pharma US INC | $634.49 | 2019-2023 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $306.46 | 2021-2023 | Erleada |
| Myriad Genetic Laboratories, INC. | $302.67 | 2023-2024 | Prolaris |
| Dendreon Pharmaceuticals LLC | $249.74 | 2021-2024 | Provenge |
| Sumitomo Pharma America, INC. | $243.39 | 2023 | Gemtesa, Orgovyx |
| Pfizer INC. | $221.96 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $217.54 | 2021-2023 | |
| Urovant Sciences INC | $203.90 | 2022 | |
| Abbvie INC. | $150.23 | 2021-2023 | Botox |
| Coloplast Corp | $149.98 | 2019-2023 | Speedicath |
| Axonics, INC. | $107.49 | 2021-2024 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $103.03 | 2021-2023 | Jelmyto |
| Medtronic, INC. | $101.28 | 2021-2023 | Interstim |
| Clarus Therapeutics INC. | $74.92 | 2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $69.06 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $63.14 | 2023 | Lynparza, Keytruda |
| Teleflex LLC | $52.71 | 2021-2023 | Urolift |
| Tolmar Pharmaceuticals, INC. | $45.24 | 2021 | |
| Olympus America INC. | $37.83 | 2023 | Itind System |
| Novo Nordisk INC | $36.77 | 2025 | Rybelsus, Ozempic |
| Allergan, INC. | $36.27 | 2021 | |
| Halozyme INC | $27.57 | 2023 | |
| Dentsply Ih Ab | $26.59 | 2023 | Lofric |
| Therapeuticsmd, INC. | $26.28 | 2021 | |
| Antares Pharma, INC. | $23.28 | 2019 | |
| Amgen INC. | $23.18 | 2022 | |
| 180 Medical, INC. | $22.97 | 2021 | |
| Agiliti Surgical, INC. | $22.50 | 2023 | Sonablate |
| Procept Biorobotics Corporation | $18.94 | 2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $17.31 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.52 | 2021 | |
| Accord Healthcare, INC. | $16.09 | 2023 | |
| Myovant Sciences INC. | $12.42 | 2021 | |
| Cook Medical LLC | $11.05 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Mcnally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.